222 related articles for article (PubMed ID: 30620140)
1. Preoperative anti-inflammatory treatment of diabetic patients does not improve recovery from cataract surgery when postoperatively treated with a combination of prednisolone acetate and nepafenac.
Danni R; Viljanen A; Aaronson A; Tuuminen R
Acta Ophthalmol; 2019 Sep; 97(6):589-595. PubMed ID: 30620140
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory Medication of Cataract Surgery in Pseudoexfoliation Syndrome - NSAID Is Needed.
Ilveskoski L; Taipale C; Tuuminen R
Curr Eye Res; 2020 Jul; 45(7):814-819. PubMed ID: 31801388
[TBL] [Abstract][Full Text] [Related]
3. Postoperative management in cataract surgery: nepafenac and preservative-free diclofenac compared.
Ylinen P; Taipale C; Lindholm JM; Laine I; Holmström E; Tuuminen R
Acta Ophthalmol; 2018 Dec; 96(8):853-859. PubMed ID: 30284393
[TBL] [Abstract][Full Text] [Related]
4. Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: a randomized trial.
Zanetti FR; Fulco EA; Chaves FR; da Costa Pinto AP; Arieta CE; Lira RP
Indian J Ophthalmol; 2012 Jul; 60(4):277-81. PubMed ID: 22824596
[TBL] [Abstract][Full Text] [Related]
5. Effect of preoperative topical nepafenac 0.1% on inflammatory response after uncomplicated cataract surgery in healthy subjects.
Cagini C; Cerquaglia A; Pellegrino A; Iannone A; Lupidi M; Fiore T
Acta Ophthalmol; 2021 Feb; 99(1):e70-e73. PubMed ID: 32558305
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of 0.1% Nepafenac versus 1% Prednisolone Acetate Eye Drops after Laser Peripheral Iridotomy: A Prospective, Randomized Trial.
Gayam K; Ramulu PY; Rengaraj V; Srinivasan K
Ophthalmol Glaucoma; 2020; 3(3):174-180. PubMed ID: 32672612
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Campa C; Salsini G; Perri P
Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
[TBL] [Abstract][Full Text] [Related]
8. Topical levofloxacin, nepafenac and prednisolone acetate medication after cataract surgery in the biggest tertiary eye hospital in Finland during 2015-2018.
Loukovaara S; Lehtinen V; Nieminen R; Moilanen J
Acta Ophthalmol; 2019 Sep; 97(6):e943-e945. PubMed ID: 30916844
[No Abstract] [Full Text] [Related]
9. Anti-inflammatory medication following cataract surgery: a randomized trial between preservative-free dexamethasone, diclofenac and their combination.
Ylinen P; Holmström E; Laine I; Lindholm JM; Tuuminen R
Acta Ophthalmol; 2018 Aug; 96(5):486-493. PubMed ID: 29369527
[TBL] [Abstract][Full Text] [Related]
10. Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac.
Sengupta S; Vasavada D; Pan U; Sindal M
Indian J Ophthalmol; 2018 Jun; 66(6):827-830. PubMed ID: 29785993
[TBL] [Abstract][Full Text] [Related]
11. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo.
McCafferty S; Harris A; Kew C; Kassm T; Lane L; Levine J; Raven M
BMC Ophthalmol; 2017 Feb; 17(1):16. PubMed ID: 28219426
[TBL] [Abstract][Full Text] [Related]
12. Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies.
Singh RP; Lehmann R; Martel J; Jong K; Pollack A; Tsorbatzoglou A; Staurenghi G; Cervantes-Coste Cervantes G; Alpern L; Modi S; Svoboda L; Adewale A; Jaffe GJ
Ophthalmology; 2017 Jun; 124(6):776-785. PubMed ID: 28268098
[TBL] [Abstract][Full Text] [Related]
13. Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.
Tzelikis PF; Morato CS; Neves NT; Hida WT; Alves MR
J Cataract Refract Surg; 2018 Apr; 44(4):440-446. PubMed ID: 29685777
[TBL] [Abstract][Full Text] [Related]
14. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.
Wolf EJ; Braunstein A; Shih C; Braunstein RE
J Cataract Refract Surg; 2007 Sep; 33(9):1546-9. PubMed ID: 17720068
[TBL] [Abstract][Full Text] [Related]
15. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
Miyake K; Ota I; Miyake G; Numaga J
J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
[TBL] [Abstract][Full Text] [Related]
16. Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy.
Nagpal M; Lambat S; Mehrotra N; Paranjpe G; Yadav H; Bhardwaj S
Indian J Ophthalmol; 2014 May; 62(5):606-9. PubMed ID: 24881610
[TBL] [Abstract][Full Text] [Related]
17. Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema.
Mathys KC; Cohen KL
Eye (Lond); 2010 Jan; 24(1):90-6. PubMed ID: 19229275
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes.
El Gharbawy SA; Darwish EA; Abu Eleinen KG; Osman MH
Eur J Ophthalmol; 2019 Jul; 29(4):453-457. PubMed ID: 30203671
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR
J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy.
Pollack A; Staurenghi G; Sager D; Mukesh B; Reiser H; Singh RP
Br J Ophthalmol; 2017 Apr; 101(4):423-427. PubMed ID: 27388251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
